Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-01-12 · last update 2026-01-12
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 01/12/2026 Updated 01/12/2026 Discontinued 01/12/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)